Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.31 | 2.31 | 0.00 |
Stocks | 97.69 | 97.69 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.86 | 19.67 |
Price to Book | 4.24 | 4.69 |
Price to Sales | 1.58 | 2.69 |
Price to Cash Flow | 17.06 | 18.26 |
Dividend Yield | 1.51 | 1.06 |
5 Years Earnings Growth | 10.88 | 17.36 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.79 | 99.68 |
Consumer Defensive | 0.09 | 0.40 |
Financial Services | 0.06 | 0.45 |
Industrials | 0.05 | 0.05 |
Technology | 0.01 | 0.15 |
Number of long holdings: 421
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.27 | 765.10 | -2.16% | |
UnitedHealth | US91324P1021 | 9.01 | 513.67 | +0.13% | |
AbbVie | US00287Y1091 | 4.68 | 180.10 | -0.62% | |
J&J | US4781601046 | 4.50 | 143.66 | -0.37% | |
Merck&Co | US58933Y1055 | 3.93 | 99.72 | +0.59% | |
Abbott Labs | US0028241000 | 3.30 | 113.04 | -0.69% | |
Thermo Fisher Scientific | US8835561023 | 3.24 | 537.19 | +0.97% | |
Intuitive Surgical | US46120E6023 | 3.08 | 542.37 | +1.32% | |
Danaher | US2358511028 | 2.49 | 238.20 | +1.43% | |
Amgen | US0311621009 | 2.43 | 258.59 | -1.01% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 740.1B | 27.63 | 10.36 | - | ||
Vanguard 500 Index Admiral | 577.55B | 28.02 | 11.39 | 13.31 | ||
Vanguard Total Stock Market Admiral | 421.1B | 27.60 | 10.34 | 12.84 | ||
Vanguard Total Intl Stock Index Inv | 206B | 7.87 | 2.85 | 4.88 | ||
Vanguard 500 Index Institutional Se | 204.82B | 28.06 | 11.42 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review